Al Jazeera: “DR Congo to Deploy Second Ebola Vaccine” (21 Sept. 2019) [Janssen]

Associated Press: “Congo to Use Second Vaccine to Fight Ebola.”, (19 Aug. 2019) [Janssen]

Associated Press: “Uganda Begins Largest Trial of Experimental Ebola Vaccine.” (2 Aug. 2019) [Janssen]

BBC News: “DR Congo to Introduce Second Ebola Vaccine.” (21 Sept. 2019) [Janssen]

BBC News: Why Is a New Ebola Vaccine so Controversial?”, (4 Aug. 2019) [Janssen]

BBC News Afrique: “Ebola : un deuxième vaccin introduit en RDC.” (12 Nov. 2019) [Janssen]

Bloomberg: “Congo Plans to Start Using J&J’s Ebola Vaccine From Next Month.” . (12 Oct. 2019) [Janssen]

Bloomberg: “Congo to Use Second Ebola Vaccine That Minister Was Resisting.”. (21 Sept. 2019) [Janssen]

Bloomberg: “J&J Ebola Shot Languishes, Making Merck Vaccine Only Option.” (21 July 2019) [Janssen]

Bloomberg: “Johnson & Johnson Giving 500,000 Ebola Shots in Congo Test.” (31 Oct. 2019) [Janssen]

“Merck’s Ebola Vaccine Helps Combat Deadly Outbreak in the Congo as the Virus Spreads.” (10 July 2019) [Janssen]

LSHTM Website: “Peter Piot Reaction to Ebola Outbreak in DRC Being Declared a Public Health Emergency of International Concern (17 Oct. 2019) [Janssen]

The New York Times: “In Congo, a New Plan to Fight Ebola Follows a Government Power Struggle.”, (26 July 2019) [Janssen]

Reuters: “Congo Has given over 200,000 People Merck Ebola Vaccine-Gov’t”., (25 Aug. 2019) [Janssen]

Reuters: “Congo to Deploy Second Ebola Vaccine.” (21 Sept. 2019) [Janssen]"

Science: “As Ebola Outbreak Rages, Plan to Test Second Vaccine Sparks Debate.”, (25 June 2019) [Janssen]

STAT: “Second Ebola Vaccine to Be Used Soon in DRC Outbreak.” (31 Oct. 2019). [Janssen]

STAT: “WHO Makes Plans for Reduced Doses of Ebola Vaccine If Needed.”, vaccine/ (26 July 2019) [Janssen]

The Telegraph: “Ebola Has Been Raging in DRC for a Year: This Is Why We Need a Second Vaccine.” (16 Aug. 2019) [Janssen]

J&J video featuring Paul Stoffels discussing the deployment of the Janssen vaccine Rwanda


  • Ebola: background

    What is Ebola?

  • Phase 2 trials

    Find out more about EBOVAC2 trials

  • Work programme

    EBOVAC2 is organised into 6 workpackages (WP)

  • Ebola+ programme

    Contributes to efforts to tackle a wide range of challenges in Ebola research

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 115861.
This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA

Cookies settings


Functional Cookies

This site uses cookies to ensure its proper functioning and cannot be deactivated from our systems. We do not use them for advertising purposes. If these cookies are blocked, certain parts of the site will not be able to function.

Measure of audience

This site uses audience measurement and analysis cookies, such as Google Analytics, in order to evaluate and improve our website.

Interactive Content

This site uses third-party components, such as NotAllowedScriptReCAPTCHA, Google Maps, which may deposit cookies on your machine. If you decide to block a component, the content will not be displayed

Other cookies

Our wepage uses cookies to manage user sessions